Raïfah Makdassi

995 total citations
10 papers, 679 citations indexed

About

Raïfah Makdassi is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Raïfah Makdassi has authored 10 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Nephrology and 4 papers in Immunology. Recurrent topics in Raïfah Makdassi's work include Complement system in diseases (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Raïfah Makdassi is often cited by papers focused on Complement system in diseases (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Raïfah Makdassi collaborates with scholars based in France. Raïfah Makdassi's co-authors include Guy Touchard, B. Mougenot, Pierre Ronco, Laure‐Hélène Noël, Gabriel Choukroun, Claire Presne, Aude Servais, Véronique Frémeaux‐Bacchi, N. El Esper and Michel E. Safar and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Medicine.

In The Last Decade

Raïfah Makdassi

10 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raïfah Makdassi France	9	387	260	237	174	108	10	679
Sabiha M. Hussain United States	9	583 1.5×	233 0.9×	83 0.4×	43 0.2×	30 0.3×	15	805
Anita W.L. Tsang Hong Kong	14	431 1.1×	171 0.7×	155 0.7×	87 0.5×	36 0.3×	16	641
Lixia Xu China	13	266 0.7×	113 0.4×	141 0.6×	74 0.4×	19 0.2×	30	464
Lihua Wu China	13	413 1.1×	87 0.3×	350 1.5×	48 0.3×	26 0.2×	28	825
Takero Naito Japan	9	294 0.8×	115 0.4×	220 0.9×	41 0.2×	27 0.3×	16	636
Dita Maixnerová Czechia	17	464 1.2×	97 0.4×	117 0.5×	103 0.6×	59 0.5×	38	656
Konstantinos Giannakakis Italy	11	230 0.6×	155 0.6×	99 0.4×	31 0.2×	20 0.2×	28	459
O. Bogenschütz Germany	7	451 1.2×	152 0.6×	99 0.4×	31 0.2×	34 0.3×	11	717
Marion Sternbach Canada	10	85 0.2×	126 0.5×	138 0.6×	263 1.5×	98 0.9×	17	529
Roberta Camilla Italy	13	606 1.6×	164 0.6×	186 0.8×	133 0.8×	72 0.7×	24	766

Countries citing papers authored by Raïfah Makdassi

Since Specialization

Citations

This map shows the geographic impact of Raïfah Makdassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raïfah Makdassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raïfah Makdassi more than expected).

Fields of papers citing papers by Raïfah Makdassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raïfah Makdassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raïfah Makdassi. The network helps show where Raïfah Makdassi may publish in the future.

Co-authorship network of co-authors of Raïfah Makdassi

This figure shows the co-authorship network connecting the top 25 collaborators of Raïfah Makdassi. A scholar is included among the top collaborators of Raïfah Makdassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raïfah Makdassi. Raïfah Makdassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fakhouri, Fádi, Marc Fila, François Provôt, et al.. (2016). Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation. Clinical Journal of the American Society of Nephrology. 12(1). 50–59. 126 indexed citations

Fakhouri, Fádi, Yahsou Delmas, François Provôt, et al.. (2013). Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases. American Journal of Kidney Diseases. 63(1). 40–48. 65 indexed citations

Monge, Matthieu, et al.. (2012). Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma. Clinical Nephrology. 81(3). 210–215. 16 indexed citations

Monge, Matthieu, Dominique Chauveau, C. Cordonnier, et al.. (2011). Localized Amyloidosis of the Genitourinary Tract. Medicine. 90(3). 212–222. 24 indexed citations

Servais, Aude, Laure‐Hélène Noël, Marie‐Agnès Dragon‐Durey, et al.. (2011). Heterogeneous pattern of renal disease associated with homozygous Factor H deficiency. Human Pathology. 42(9). 1305–1311. 31 indexed citations

Temmar, M., Sophie Liabeuf, C. Renard, et al.. (2009). Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. Journal of Hypertension. 28(1). 163–169. 147 indexed citations

Messiaen, T., Sophie Déret, B. Mougenot, et al.. (2000). Adult Faconi Syndrome Secondary to Light Chain Gammopathy: Clinicopathologic Heterogeneity and Unnsual Features in 11 Patients. Medicine. 79(3). 135–154. 153 indexed citations

Fournier, Albert, A Pruna, N. El Esper, et al.. (2000). Captopril prevention project—what shall we do about captopril and the risk of stroke?. Nephrology Dialysis Transplantation. 15(1). 2–5. 15 indexed citations

Esper, I. El, et al.. (1997). Steady-state captopril renography: Continuous monitoring of the captopril-induced increase in99mTc-MAG3 mean parenchymal transit time in renovascular hypertension. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 739–744. 1 indexed citations

10.

Lelongt, Brigitte, B. Mougenot, Guy Touchard, et al.. (1995). Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney International. 48(1). 72–79. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact